天津大学教师个人主页系统贺小宁 Matching-adjusted indirect comparison and cost-effectiveness of mitoxantrone hydrochloride liposome versus Chidamide in relapsed or refractory peripheral T-cell lymphoma in China Home

中文

Brief Introduction
Education Background
Research Interests
Courses
Professional Membership
Positions & Employments
Academic achievements
Honors & Awards
Team
Album

Xiaoning He

School

School of Pharmaceutical Science and Technology, Medical College

Professional Title

Associate professor

Discipline

Health and Pharmacy Administration

Other Contact Information

Selected Papers

Current position: Home > Academic Achievements > Selected Papers

Matching-adjusted indirect comparison and cost-effectiveness of mitoxantrone hydrochloride liposome versus Chidamide in relapsed or refractory peripheral T-cell lymphoma in China

Hits:

Journal:Expert Rev Pharmacoecon Outcomes Res

All the Authors:Liu Y, He X*

Translation or Not:no

CN No.:null

Pre One:Can DRG payment under global budget with price adjustment curb the soaring healthcare costs? Insights from China's reform and its underlying mechanism

Next One:Cost-effectiveness analysis of trilaciclib for reducing the incidence of chemotherapy-induced myelosuppression among patients with extensive-stage small cell lung cancer in China